Genetic variants in protein kinase C zeta gene and type 2 diabetes risk: A case-control study of a Chinese Han population

Diabetes/Metabolism Research and Reviews

Volumn 24, Issue 6, 2008, Pages 480-485

  Qin, Lei ^a   Zhou, Ling ^a   Wu, Xueji ^a   Cheng, Jinluo ^b   Wang, Jingsong ^c   Du, Yunfeng ^b   Hu, Jihong ^b   Shen, Moyu ^b   Zhou, Jinyi ^a,d  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c YANGZHOU UNIVERSITY   (China)

^d JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Protein kinase C zeta gene; Single nucleotide polymorphisms; Type 2 diabetes mellitus

Indexed keywords

CYTOSINE; GLUCOSE; GUANINE; INSULIN; PROTEIN KINASE C ZETA; THYMINE;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; SEQUENCE TAGGED SITE; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DIABETES MELLITUS, TYPE 2; DNA PRIMERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERVIEWS AS TOPIC; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN KINASE C; QUESTIONNAIRES; RISK FACTORS; VARIATION (GENETICS);

EID: 53349119120     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.882     Document Type: Article

References (25)

1. Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787.
2. Du W, Sun H, Wang H, et al. Confirmation of susceptibility gene loci on chromosome 1 in northern China Han families with type 2 diabetes. Chin Med J (Engl) 2001; 114: 876-878.
3. Liu LZ, He AB, Liu XJ, Li Y, Chang YS, Fang FD. Protein kinase Czeta and glucose uptake. Biochemistry (Mosc) 2006; 71: 701-706.
4. Tremblay F, Lavigne C, Jacques H, Marette A. Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities. Diabetes 2001; 50: 1901-1910.
5. Ravichandran LV, Esposito DL, Chen J, Quon MJ. Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J Biol Chem 2001; 276: 3543-3549.
6. Liu YF, Paz K, Herschkovitz A, et al. Insulin stimulates PKCzeta -mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J Biol Chem 2001; 276: 14459-14465.
7. Sun HX, Du WN, Zuo J, et al. The association of two single nucleotide polymorphisms in PRKCZ and UTS2 respectively with type 2 diabetes in Han people of northern China. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2002; 24: 223-227.
8. Liu Z, Sun HX, Zhang YW, et al. Effect of SNPs in protein kinase Cz gene on gene expression in the reporter gene detection system. World J Gastroenterol 2004; 10: 2357-2360.
9. Johnson GC, Esposito L, Barratt BJ, et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29: 233-237.
10. Alwan A, King H (eds). Report of a WHO Consultation. In Defnition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva; World Health Org., Department of Noncommunicable Disease Surveillance; 1999; 1-59.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
12. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
13. Carlson CS, Eberle MA, Rieder MJ, et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 1: 106-120.
14. Ke X, Collins A, Ye S. PIRA PCR designer for restriction analysis of single nucleotide polymorphisms. Bioinformatics 2001; 17: 838-839.
15. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Star Soc B 1995; 57: 289-300.
16. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.
17. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661.
18. Dempsey EC, Newton AC, Mochly-Rosen D, et al. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 2000; 279: L429-L438.
19. Moscat J, Diaz-Meco MT. The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters. EMBO Rep 2000; 1: 399-403.
20. Nakanishi H, Exton JH. Purification and characterization of the zeta isoform of protein kinase C from bovine kidney. J Biol Chem 1992; 267: 16347-16354.
21. Yedovitzky M, Mochly-Rosen D, Johnson JA, et al. Translocation inhibitors define specificity of protein kinase C isoenzymes in pancreatic beta-cells. J Biol Chem 1997; 272: 1417-1420.
22. Hirai T, Chida K. Protein kinase Czeta (PKCzeta): activation mechanisms and cellular functions. J Biochem (Tokyo) 2003; 133: 1-7.
23. Yaney GC, Korchak HM, Corkey BE. Long-chain acyl CoA regulation of protein kinase C and fatty acid potentiation of glucose-stimulated insulin secretion in clonal beta-cells. Endocrinology 2000; 141: 1989-1998.
24. Iakoubov R, Izzo A, Yeung A, Whiteside CI, Brubaker PL. Protein kinase Czeta is required for oleic acid-induced secretion of glucagon-like peptide-1 by intestinal endocrine L cells. Endocrinology 2007; 148: 1089-1098.
25. Kanoh Y, Bandyopadhyay G, Sajan MP, Standaert ML, Farese RV. Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats. Endocrinology 2001; 142: 1595-1605.